• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, April 3, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

BU researcher receives NIH grant to study Down syndrome

Bioengineer by Bioengineer
July 16, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Boston)–Tarik F. Haydar, PhD, professor of anatomy and neurobiology at Boston University School of Medicine (BUSM), has been awarded a two-year Exploratory/Developmental Research Grant Award (R21) from the National Institutes of Health (NIH).

Funds from the $453,750 grant will be used to develop human stem cell-derived cultures to study a developmental abnormality in the formation and/or maintenance of white matter in the brain of people with Down syndrome. Pilot funds for this research were awarded by the BU Clinical & Translational Science Institute and an administrative supplement from the National Institute of Neurological Disorders and Stroke.

Haydar received his doctorate degree from the University of Maryland School of Medicine focusing on brain development in Down syndrome with Bruce Krueger, PhD. He completed postdoctoral studies at Yale University with Pasko Rakic, MD, PhD, examining control of forebrain neural precursor development. He then started his own independent laboratory at Children’s National Medical Center in Washington, DC, in 2002.

Haydar joined BUSM in 2010 where he studies mammalian brain development using state-of-the-art molecular and surgical techniques. Using in utero electroporation (an electrical pulse to create temporary pores in cell membranes), in vivo genetic fate mapping (to study the embryonic origin) and gene expression profiling, his goal is to understand how the multiple populations of neural stem cells and progenitor cells in the embryonic brain generate the cerebral cortex. In addition, Haydar is using similar approaches to characterize brain development and function in Down syndrome using experimental models and human samples.

Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is typically associated with physical growth delays, mild to moderate intellectual disability and characteristic facial features.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development.

###

Media Contact
Gina DiGravio
[email protected]

Tags: Medicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Levothyroxine Shows No Benefit in Older Adults

April 3, 2026

New Study Links Obstructive Sleep Apnea to Increased Risk of Mortality and Cardiovascular Events

April 2, 2026

Excessive Pyroptosis Worsens Flu and MRSA Pneumonia

April 2, 2026

Noninvasive Targeting of Deep Brain Regions: A Breakthrough Beyond Surgery and Medication

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing the Body from Within: The Rise of ‘Transformation Electrodes’

Levothyroxine Shows No Benefit in Older Adults

National Dust Storm Impact on Tourism and Infrastructure

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.